Clinical trials in Immenhausen – page 2

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) and its various stages, testing innovative therapies and treatment combinations. Research includes studies on metastatic disease and post-surgery treatments.

• Advanced treatment combinations
• Immunotherapy approaches
• Post-surgical therapies

Multiple studies evaluating novel drug combinations with established treatments like pembrolizumab and chemotherapy.

Research targeting various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Studies focus on improving patient outcomes and testing new therapeutic approaches.

• COPD management
• Fibrosis treatments
• Respiratory therapeutics

Investigations into new medications for managing chronic respiratory conditions and preventing disease progression.

Innovative research exploring targeted therapies and personalized treatment approaches for various lung conditions. Studies include both early-stage and advanced disease management strategies.

• Novel drug development
• Combination therapies
• Treatment optimization

Focus on developing more effective and personalized treatment options for patients with various lung diseases.